Rare diseases
Investigational molecules
Locations
Back to Italy907 clinical trials in Bologna, Italy across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes
ItalyPhase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer
ItalyPhase 3 Study of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy Patients
ItalyRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
ItalyA Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus
ItalyEfficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1
ItalyLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
ItalyA Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
ItalySafety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
ItalyPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
ItalyPhase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
ItalyPhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Immune Thrombocytopenia and various forms of blood cancers including Acute Myeloid Leukemia and Multiple Myeloma. These trials aim to evaluate novel therapeutic approaches and combination treatments.
Studies include evaluation of new compounds and their safety profiles in treating various blood-related conditions.
Comprehensive studies on inflammatory bowel conditions, focusing on Crohn's Disease and Ulcerative Colitis. Research aims to develop more effective treatments for patients with moderate to severe disease activity.
Trials evaluate both induction therapy and long-term treatment options for gastrointestinal conditions.
Investigation of treatments for sleep disorders including Narcolepsy and Idiopathic Hypersomnia, along with research into Chronic Inflammatory Demyelinating Polyneuropathy.
Focus on developing safer and more effective therapies for various neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
